Comprehensive HIV and Harm Prevention Via Telehealth

Description

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Conditions

HIV Infections

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial

Comprehensive HIV and Harm Prevention Via Telehealth

Condition
HIV Infections
Intervention / Treatment

-

Contacts and Locations

Miami

IDEA Miami, Miami, Florida, United States, 33136

Miami

IDEA Syringe Services Program, Miami, Florida, United States, 33136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * age 18 or older
  • * able to speak English or Spanish
  • * willing and able to sign informed consent, provide locator information and medical records release
  • * non-reactive result on rapid HIV test
  • * use of SSP to exchange syringes 2 times in the past 3 months
  • * planning to stay in the area for 12 months
  • * reactive HIV test
  • * currently on medications for opioid use disorder (MOUD) by urine drug screen
  • * currently on PrEP by self-report
  • * Principal or site investigator discretion
  • * currently in prison or jail
  • * current enrollment in Clinical Trials Network 121
  • * receipt of tele-harm reduction in previous 3 months
  • * signs or symptoms of acute HIV infection

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Miami,

Hansel Tookes, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Tyler Bartholomew, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

2027-10-09